167 related articles for article (PubMed ID: 38141870)
1. Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines.
; Badell ML; Prabhu M; Dionne J; Tita ATN; Silverman NS;
Am J Obstet Gynecol; 2024 Apr; 230(4):B2-B11. PubMed ID: 38141870
[TBL] [Abstract][Full Text] [Related]
2. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
; Dionne-Odom J; Tita AT; Silverman NS
Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
[TBL] [Abstract][Full Text] [Related]
3. Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017.
; Dotters-Katz SK; Kuller JA; Hughes BL
Am J Obstet Gynecol; 2021 Sep; 225(3):B8-B18. PubMed ID: 34116035
[TBL] [Abstract][Full Text] [Related]
4. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prevention of viral hepatitis in pregnancy.
Dionne-Odom J; Cozzi GD; Franco RA; Njei B; Tita ATN
Am J Obstet Gynecol; 2022 Mar; 226(3):335-346. PubMed ID: 34516961
[TBL] [Abstract][Full Text] [Related]
7. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
8. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Infection in Pregnancy: An Update on Evidence-Based Management.
Sirilert S; Tongsong T
Obstet Gynecol Surv; 2020 Sep; 75(9):557-565. PubMed ID: 32997148
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
Ndububa D; Kuti O; Awowole I; Adekanle O; Ijarotimi O; Makinde O; Adeyemi A; Anyabolu C; Ijadunola M
BMJ Open; 2022 Nov; 12(11):e063482. PubMed ID: 36351715
[TBL] [Abstract][Full Text] [Related]
12. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
[TBL] [Abstract][Full Text] [Related]
14. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
[TBL] [Abstract][Full Text] [Related]
15. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C in pregnancy: screening, treatment, and management.
; Hughes BL; Page CM; Kuller JA
Am J Obstet Gynecol; 2017 Nov; 217(5):B2-B12. PubMed ID: 28782502
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
18. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
[TBL] [Abstract][Full Text] [Related]
19. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
20. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
